We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomized trial shows benefits of tislelizumab plus chemotherapy in gastric cancer, indicating effective long-term treatment strategies.
ClinicalTrials.gov Identifier: NCT03777657.
No takes yet. Share an insight, caveat, or question.
Cruz-Correa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: